Fig. 6From: EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastomaEREG function analysis. A PDL1 expression of EREG-KD and EREG-NC in the U87 and U251 cell lines. B FDX1 expression of EREG-KD and EREG-NC in the U87 and U251 cell lines. C Colony formation assays were performed on U87 and U251 cell lines. D Invasion ability assays were performed on U87 and U251 cell lines by transwell. E Migration ability assays were performed on U87 and U251 cell lines by transwell.*P < 0.05, **P < 0.01, ***P < 0.001. Error bars indicate the mean ± SDBack to article page